In addition, we observed how MAP17 levels increase in cancer cells during tumor progression, being higher in metastatic samples than in primary tumor samples, suggesting that this protein could have an important role in progression from primary to metastatic tumors, where this protein usually has higher expression levels1,8,12,13. Here, PDZK1IP1 is linked to metastatic neoplasm.